Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer Patients
Open Access
- 11 December 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Microenvironment
- Vol. 2 (1), 1-7
- https://doi.org/10.1007/s12307-008-0016-1
Abstract
Chemokines and their receptors are implicated in formation of colorectal cancer metastases. Especially CXCR4 is an important factor, determining migration, invasiveness, metastasis and proliferation of colorectal cancer cells. Object of this study was to determine expression of CXCR4 in tumor tissue of colorectal cancer patients and associate CXCR4 expression levels to clinicopathological parameters. Levels of CXCR4 expression of a random cohort of patients, who underwent primary curative resection of a colorectal carcinoma, were retrospectively determined by quantitative real-time RT-PCR and semi-quantitative analyses of immunohistochemical stained paraffin sections. Expression levels were associated to clinicopathological parameters. Using RT-PCR we found that a high expression of CXCR4 in the primary tumor was an independent prognostic factor for a poor disease free survival (p = 0.03, HR: 2.0, CI = 1.1–3.7). Immunohistochemical staining showed that nuclear distribution of CXCR4 in the tumor cells was inversely associated with disease free and overall survival (p = 0.04, HR: 2.6, CI = 1.0–6.2), while expression in the cytoplasm was not associated with prognosis. In conclusion, our study showed that a high expression of nuclear localized CXCR4 in tumor cells is an independent predictor for poor survival for colorectal cancer patients.Keywords
This publication has 33 references indexed in Scilit:
- CXCR4–CCR5: A couple modulating T cell functionsProceedings of the National Academy of Sciences, 2008
- Clinical impact of HLA class I expression in rectal cancerCancer Immunology, Immunotherapy, 2007
- A Significant Correlation between Nuclear CXCR4 Expression and Axillary Lymph Node Metastasis in Hormonal Receptor Negative Breast CancerAnnals of Surgical Oncology, 2007
- Manipulating the chemokine‐chemokine receptor network to treat cancerCancer, 2007
- Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: Potential regulation by ligand-dependent degradation and HIF-1αBiochemical and Biophysical Research Communications, 2006
- Chemokine Receptor CXCR4 Expression in Patients With Melanoma and Colorectal Cancer Liver Metastases and the Association With Disease OutcomeAnnals of Surgery, 2006
- The role of CXCR4 receptor expression in breast cancer: a large tissue microarray studyBreast Cancer Research and Treatment, 2005
- Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal CancerClinical Cancer Research, 2005
- CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivoCancer Gene Therapy, 2004
- THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.The Lancet, 1889